Ertaczo approved by FDA for athlete's foot.(Pipeline Previews) From: Journal of Drugs in Dermatology | Date: March 1, 2004 | COPYRIGHT 2004 Journal of Drugs in Dermatology. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Mylan Pharmaceuticals announced that the FDA approved the company's antifungal cream Ertaczo (sertaconazole nitrate) for athlete's foot, which will be licensed to Johnson & Johnson (J & J) for marketing and sales. Sertaconazole is an imidazole derivative antifungal indicated for the treatment of tinea pedis. Ertaczo...